Search

Your search keyword '"D Jane Holmes-Walker"' showing total 2 results
Start Over Author "D Jane Holmes-Walker" Publisher mary ann liebert inc
2 results on '"D Jane Holmes-Walker"'

1. Driving with Type 1 Diabetes: Real-World Evidence to Support Starting Glucose Level and Frequency of Monitoring During Journeys

Author

Steven, Trawley, Amanda N, Stephens, Sybil A, McAuley, Jane, Speight, Christel, Hendrieckx, Sara, Vogrin, Melissa H, Lee, Barbora, Paldus, Leon A, Bach, Morton G, Burt, Neale D, Cohen, Peter G, Colman, Elizabeth A, Davis, D Jane, Holmes-Walker, Alicia J, Jenkins, Joey, Kaye, Anthony C, Keech, Kavita, Kumareswaran, Richard J, MacIsaac, Roland W, McCallum, Catriona M, Sims, Stephen N, Stranks, Vijaya, Sundararajan, Glenn M, Ward, Timothy W, Jones, and David N, O'Neal

Subjects
Adult, Blood Glucose, Male, Medical Laboratory Technology, Diabetes Mellitus, Type 1, Endocrinology, Blood Glucose Self-Monitoring, Endocrinology, Diabetes and Metabolism, Humans, Hypoglycemic Agents, Insulin, Hypoglycemia
Abstract

There is limited evidence supporting the recommendation that drivers with insulin-treated diabetes need to start journeys with glucose90 mg/dL. Glucose levels of drivers with type 1 diabetes were monitored for 3 weeks using masked continuous glucose monitoring (CGM). Eighteen drivers (median [IQR] age 40 [35, 51] years; 11 men) undertook 475 trips (duration 15 [13, 21] min). Hypoglycemia did not occur in any trip starting with glucose90 mg/dL (92%

Published
2022

2. Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections

Author

Christel Hendrieckx, Kavita Kumareswaran, Sara Vogrin, D Jane Holmes-Walker, Jane Speight, Leon A. Bach, Elizabeth A. Davis, David N O'Neal, Martin de Bock, Mary B Abraham, Timothy W. Jones, Roland W. McCallum, Richard J MacIsaac, Steven Trawley, Vijaya Sundararajan, Morton G. Burt, Catriona M. Sims, Alicia J. Jenkins, Anthony C Keech, Joey Kaye, Peter G. Colman, Barbora Paldus, Stephen N Stranks, Neale Cohen, Glenn M. Ward, Sybil A McAuley, and Melissa H Lee

Subjects
Adult, Blood Glucose, Insulin pump, medicine.medical_specialty, endocrine system diseases, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, 030209 endocrinology & metabolism, Hypoglycemia, 03 medical and health sciences, Insulin Infusion Systems, 0302 clinical medicine, Endocrinology, Interquartile range, Internal medicine, Blood Glucose Self-Monitoring, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Insulin, 030212 general & internal medicine, Glycated Hemoglobin, Type 1 diabetes, business.industry, Australia, nutritional and metabolic diseases, medicine.disease, Confidence interval, Medical Laboratory Technology, Diabetes Mellitus, Type 1, business
Abstract

Background: This prerandomization analysis from the Australian HCL-Adult trial (registration number: ACTRN12617000520336) compared masked continuous glucose monitoring (CGM) metrics among adults using insulin pumps versus multiple daily injections (MDIs), who were all self-monitoring blood glucose (SMBG). Methods: Adults with type 1 diabetes, using an insulin pump or MDIs without real-time CGM (and entering a trial of closed-loop technology), were eligible. MDI users were given an insulin dosage calculator. All participants received diabetes and carbohydrate-counting education, then wore masked CGM sensors for 3 weeks. Ethics Approval: HREC-D 088/16 Results: Adults using MDIs (n = 61) versus pump (n = 59) did not differ by age, sex, diabetes duration, insulin total daily dose, or HbA1c at baseline. After education, median (interquartile range) CGM time in range (TIR) 70-180 mg/dL (3.9-10.0 mmol/L) was 54% (47, 62) for those using MDIs and 56% (48, 66) for those using pump (P = 0.40). All CGM metrics were equivalent for 24 h/day for MDI and pump users. Overnight, those using MDIs (vs. pump) spent more time with glucose

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results